173 related articles for article (PubMed ID: 16980337)
1. In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes.
Vecchietti S; Grandi E; Severi S; Rivolta I; Napolitano C; Priori SG; Cavalcanti S
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H56-65. PubMed ID: 16980337
[TBL] [Abstract][Full Text] [Related]
2. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
3. Computer simulation of wild-type and mutant human cardiac Na+ current.
Vecchietti S; Rivolta I; Severi S; Napolitano C; Priori SG; Cavalcanti S
Med Biol Eng Comput; 2006 Mar; 44(1-2):35-44. PubMed ID: 16929919
[TBL] [Abstract][Full Text] [Related]
4. Simulation of Ca-calmodulin-dependent protein kinase II on rabbit ventricular myocyte ion currents and action potentials.
Grandi E; Puglisi JL; Wagner S; Maier LS; Severi S; Bers DM
Biophys J; 2007 Dec; 93(11):3835-47. PubMed ID: 17704163
[TBL] [Abstract][Full Text] [Related]
5. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism.
Clancy CE; Rudy Y
Circulation; 2002 Mar; 105(10):1208-13. PubMed ID: 11889015
[TBL] [Abstract][Full Text] [Related]
6. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
[TBL] [Abstract][Full Text] [Related]
7. Mutations in cardiac sodium channels: clinical implications.
Liu H; Clancy C; Cormier J; Kass R
Am J Pharmacogenomics; 2003; 3(3):173-9. PubMed ID: 12814325
[TBL] [Abstract][Full Text] [Related]
8. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation.
O'Hara T; Virág L; Varró A; Rudy Y
PLoS Comput Biol; 2011 May; 7(5):e1002061. PubMed ID: 21637795
[TBL] [Abstract][Full Text] [Related]
9. Contributions of sustained INa and IKv43 to transmural heterogeneity of early repolarization and arrhythmogenesis in canine left ventricular myocytes.
Flaim SN; Giles WR; McCulloch AD
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2617-29. PubMed ID: 16829642
[TBL] [Abstract][Full Text] [Related]
10. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
Flaim SN; Giles WR; McCulloch AD
Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmia formation in subclinical ("silent") long QT syndrome requires multiple insults: quantitative mechanistic study using the KCNQ1 mutation Q357R as example.
O'Hara T; Rudy Y
Heart Rhythm; 2012 Feb; 9(2):275-82. PubMed ID: 21952006
[TBL] [Abstract][Full Text] [Related]
13. Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
Hu D; Barajas-Martinez H; Nesterenko VV; Pfeiffer R; Guerchicoff A; Cordeiro JM; Curtis AB; Pollevick GD; Wu Y; Burashnikov E; Antzelevitch C
Pacing Clin Electrophysiol; 2010 Mar; 33(3):274-85. PubMed ID: 20025708
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.
Yong SL; Ni Y; Zhang T; Tester DJ; Ackerman MJ; Wang QK
Biochem Biophys Res Commun; 2007 Jan; 352(2):378-83. PubMed ID: 17118339
[TBL] [Abstract][Full Text] [Related]
15. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
Stokoe KS; Thomas G; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):69-84. PubMed ID: 17023504
[TBL] [Abstract][Full Text] [Related]
16. Differential calcium sensitivity in Na
Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
[TBL] [Abstract][Full Text] [Related]
17. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
18. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
[TBL] [Abstract][Full Text] [Related]
19. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
[TBL] [Abstract][Full Text] [Related]
20. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation.
Windle JR; Geletka RC; Moss AJ; Zareba W; Atkins DL
Ann Noninvasive Electrocardiol; 2001 Apr; 6(2):153-8. PubMed ID: 11333173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
